Proliferative Diabetic Retinopathy (PDR) Terminated Phase 2 Trials for Ranibizumab (DB01270)
Also known as: PDR - Proliferative Diabetic Retinopathy / Diabetic Proliferative Retinopathy / Proliferative Diabetic Retinopathy / Proliferative retinopathy due to diabetes mellitus (disorder) / Retinopathy due to diabetes mellitus (disorder) / Diabetic retinopathy / Retinopathy diabetic
| Indication | Status | Phase |
|---|---|---|
| DBCOND0056889 (Proliferative Diabetic Retinopathy (PDR)) | Terminated | 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT00668785 | Intravitreal Ranibizumab to Treat Macular Edema After Panretinal Photocoagulation (Phase II) | Treatment |